Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BioMed Ventures

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 25
Average round size
info
The average size of a deal this fund participated in
$33M
Portfolio companies 18
Rounds per year 2.08
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.28
Exits 9
Key employees Soon
Stages of investment
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
Summary

BioMed Ventures is the famous VC, which was founded in 2010. The main department of described VC is located in the San Diego. The company was established in North America in United States.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the BioMed Ventures, startups are often financed by Valley Ventures, Solstice Capital, Clarus Ventures. The meaningful sponsors for the fund in investment in the same round are New Enterprise Associates, Sofinnova Investments, Solas BioVentures. In the next rounds fund is usually obtained by Solas BioVentures, Sofinnova Investments, Silicon Valley Bank.

Considering the real fund results, this VC is 15 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this BioMed Ventures performs on 11 percentage points more the average number of lead investments. The high activity for fund was in 2015. The increased amount of exits for fund were in 2015. Deals in the range of 10 - 50 millions dollars are the general things for fund. The average startup value when the investment from BioMed Ventures is 50-100 millions dollars. The fund is generally included in less than 2 deals every year.

The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Medical Device, Health Care. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Auspex Pharmaceuticals, Genalyte, Compass Therapeutics For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of BioMed Ventures:
Typical Co-investors
BioMed Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after BioMed Ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Alabbar Enterprises Dubai, United Arab Emirates
APAC Realty Central, Central Region, Singapore
APEX Limited Partners -
Beta Catalyst Chiyoda, Japan
Canna Angels -
Flightpath Ventures California, San Francisco, United States
Frontier Communications Connecticut, Stamford, United States
iVision Ventures Beijing, Beijing, China
Luzerner Kantonalbank Lucerne, Luzern, Switzerland
Monarch Ventures Charlotte, North Carolina, United States
Runway Venture Partners New York, New York, United States
Samwhan Corporation -
SNBL USA -
Strandview Capital California, El Segundo, United States
Tianchuang Zhixing (Beijing) Touzi Guanli Zixun Youxian Gongsi Beijing, China, Haidian
Toibb Enterprises -
Xssentials LLC -
Yiqiao Gufen -
Zhangshushi Fenghua Touzi guanli Zhongxin China, Guangdong, Jiangxi

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Fauna Bio

Biotechnology
Health Care
Hospital
Medical
$9M21 Sep 2021 Berkeley, California, United States

Effector Therapeutics

Biotechnology
Health Care
Medical
$60M26 Aug 2021 San Diego, California, United States

Amplyx Pharmaceuticals

Biotechnology
Clinical Trials
Medical
Pharmaceutical
$53M19 May 2020 San Diego, California, United States

Compass Therapeutics

Biopharma
Biotechnology
Therapeutics
$49M12 Jul 2018 Boston, Massachusetts, United States

AEGEA Medical

Biotechnology
Health Care
Manufacturing
Medical Device
$40M02 Jan 2018 Redwood City, California, United States

Amplyx Pharmaceuticals

Biotechnology
Clinical Trials
Medical
Pharmaceutical
$67M01 Aug 2017 San Diego, California, United States

Effector Therapeutics

Biotechnology
Health Care
Medical
$38M24 Jul 2017 San Diego, California, United States

NeuroVia

Biopharma
Biotechnology
Drug Discovery
Medical
Therapeutics
$14M20 Jul 2017 San Francisco, California, United States

Sensely

Enterprise Software
Health Care
Information Services
Internet
$8M14 Feb 2017 San Francisco, California, United States
News
Fauna Bio Raises $9M in Seed Funding

– Fauna Bio is an Emeryville, California-based biotechnology company leveraging animal genomics to improve human health.
– The company raised $9m in Seed funding.
– The round was led by LifeForce Capital with participation from True Ventures, Boom Capital, Pacific 8 Ventures, BioMed Ventures, Vibe Capital and Arcadia Science.
– The new investment will be used to expand its drug discovery platform Convergence while accelerating the discovery of new therapeutic targets for human diseases across a broad range of indications.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BioMed Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: